Hasil Pencarian - Mark J. Smyth

Perbaiki Hasil
  1. 1
    Targeting immune checkpoints in hematological malignancies

    Targeting immune checkpoints in hematological malignancies oleh Basit Salik, Mark J. Smyth, Kyohei Nakamura

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Retracted: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity

    Retracted: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity oleh William C. Dougall, Amelia Roman Aguilera, Mark J. Smyth

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?

    Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade? oleh Jake S. O’Donnell, Mark J. Smyth, Michele W. L. Teng

    Diterbitkan 2016-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy

    Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy oleh Sara Mastaglio, Eric Wong, Travis Perera, Jane Ripley, Piers Blombery, Mark J. Smyth, Rachel Koldej, David Ritchie

    Diterbitkan 2018-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome

    Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome oleh Jing Liu, Jake S. O’Donnell, Juming Yan, Jason Madore, Stacey Allen, Mark J. Smyth, Michele W. L. Teng

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    The role of NK cells and CD39 in the immunological control of tumor metastases

    The role of NK cells and CD39 in the immunological control of tumor metastases oleh Haiyan Zhang, Dipti Vijayan, Xian-Yang Li, Simon C. Robson, Nishamol Geetha, Michele W. L. Teng, Mark J. Smyth

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer

    RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer oleh Elizabeth Ahern, Heidi Harjunpää, Jake S. O'Donnell, Stacey Allen, William C. Dougall, Michele W. L. Teng, Mark J. Smyth

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer

    An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancer oleh Alexander Liede, Rohini K. Hernandez, Sally W. Wade, Ronghai Bo, Nathan C. Nussbaum, Elizabeth Ahern, William C. Dougall, Mark J. Smyth

    Diterbitkan 2018-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Plasmodium strain determines dendritic cell function essential for survival from malaria.

    Plasmodium strain determines dendritic cell function essential for survival from malaria. oleh Michelle N Wykes, Xue Q Liu, Lynette Beattie, Danielle I Stanisic, Katryn J Stacey, Mark J Smyth, Ranjeny Thomas, Michael F Good

    Diterbitkan 2007-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Physicochemical properties that control protein aggregation also determine whether a protein is retained or released from necrotic cells

    Physicochemical properties that control protein aggregation also determine whether a protein is retained or released from necrotic cells oleh Andre L. Samson, Bosco Ho, Amanda E. Au, Simone M. Schoenwaelder, Mark J. Smyth, Stephen P. Bottomley, Oded Kleifeld, Robert L. Medcalf

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy

    Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy oleh Jing Liu, Elisa A. Rozeman, Jake S. O’Donnell, Stacey Allen, Lorenzo Fanchi, Mark J. Smyth, Christian U. Blank, Michele W.L. Teng

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy

    Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy oleh Deepak Mittal, Dipti Vijayan, Joost Neijssen, Joost Kreijtz, Maurice M. J. M. Habraken, Hans Van Eenennaam, Andrea Van Elsas, Mark J. Smyth

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting

    IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting oleh Kazuyoshi Takeda, Masafumi Nakayama, Yoshihiro Hayakawa, Yuko Kojima, Hiroaki Ikeda, Naoko Imai, Kouetsu Ogasawara, Ko Okumura, David M. Thomas, Mark J. Smyth

    Diterbitkan 2017-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases

    Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases oleh Dipti Vijayan, Deborah S. Barkauskas, Kimberley Stannard, Erin Sult, Rebecca Buonpane, Kazuyoshi Takeda, Michele W. L. Teng, Kris Sachsenmeier, Carl Hay, Mark J. Smyth

    Diterbitkan 2017-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients

    Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients oleh Vijayendra Dasari, Andrea Schuessler, Corey Smith, Yide Wong, John J Miles, Mark J Smyth, George Ambalathingal, Ross Francis, Scott Campbell, Daniel Chambers, Rajiv Khanna

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis

    Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis oleh Eva M. Putz, Camille Guillerey, Kevin Kos, Kimberley Stannard, Kim Miles, Rebecca B. Delconte, Kazuyoshi Takeda, Sandra E. Nicholson, Nicholas D. Huntington, Mark J. Smyth

    Diterbitkan 2017-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)

    Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multi... oleh Elizabeth Ahern, Annette Cubitt, Emma Ballard, Michele W. L. Teng, William C. Dougall, Mark J. Smyth, David Godbolt, Rishendran Naidoo, Amanda Goldrick, Brett G. M. Hughes

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity

    CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity oleh Amelia Roman Aguilera, Viviana P. Lutzky, Deepak Mittal, Xian-Yang Li, Kimberley Stannard, Kazuyoshi Takeda, Günter Bernhardt, Michele W. L. Teng, William C. Dougall, Mark J. Smyth

    Diterbitkan 2018-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis.

    Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis. oleh Amanda C Stanley, Yonghong Zhou, Fiona H Amante, Louise M Randall, Ashraful Haque, Daniel G Pellicci, Geoff R Hill, Mark J Smyth, Dale I Godfrey, Christian R Engwerda

    Diterbitkan 2008-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation

    DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation oleh Ludovic Martinet, Lucas Ferrari De Andrade, Camille Guillerey, Jason S. Lee, Jing Liu, Fernando Souza-Fonseca-Guimaraes, Dana S. Hutchinson, Tatiana B. Kolesnik, Sandra E. Nicholson, Nicholas D. Huntington, Mark J. Smyth

    Diterbitkan 2015-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: